---
title: "Guggenheim Remains a Buy on Pyxis Oncology (PYXS)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306281515.md"
description: "In a report released yesterday, from Guggenheim reiterated a Buy rating on Pyxis Oncology, with a price target of $7.00. The company’s shares closed yesterday at $1.68.Pyxis Oncology has an analyst consensus of Strong Buy, with a price target consensus of $8.15, which is a 385.12% upside from current levels. In a report released today, Wells Fargo also reiterated a Buy rating on the stock with a $19.00 price target."
datetime: "2026-11-20T13:15:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306281515.md)
  - [en](https://longbridge.com/en/news/306281515.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306281515.md)
generator: "portal-rs"
---

# Guggenheim Remains a Buy on Pyxis Oncology (PYXS)

In a report released yesterday, from Guggenheim reiterated a Buy rating on Pyxis Oncology, with a price target of $7.00. The company’s shares closed yesterday at $1.68.

Pyxis Oncology has an analyst consensus of Strong Buy, with a price target consensus of $8.15, which is a 385.12% upside from current levels. In a report released today, Wells Fargo also reiterated a Buy rating on the stock with a $19.00 price target.

### Related Stocks

- [PYXS.US](https://longbridge.com/en/quote/PYXS.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)

## Related News & Research

- [PYXS: MICVO showed durable responses in phase 1, supporting a planned global Phase 3 trial](https://longbridge.com/en/news/306107284.md)
- [William Blair upgrades Pyxis Oncology to Outperform from Market Perform](https://longbridge.com/en/news/306274949.md)
- [SanDisk Stock Price Forecast: TrendForce Sees 1Q27 NAND Contract Prices Flat to Down 5%, Shares Face About 40% Downside](https://longbridge.com/en/news/306297576.md)
- [AI solves 167-year-old maths problem, Anthropic researcher claims](https://longbridge.com/en/news/306318851.md)
- [Trump: 'Have lot of respect' for Anthropic, CEO Amodei](https://longbridge.com/en/news/306312307.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**